Get Premium to unlock powerful stock data
National Research Corp logo

National Research Corp $ 38.88 1.11 (2.94%)

Volume:
54,754
Avg Vol (1m):
53,333
Market Cap $:
989.46 Mil
Enterprise Value $:
936.31 Mil
PE Ratio:
27.59
PB Ratio:
11.90
Warning! GuruFocus has detected 1 Medium warning sign with NRC. Click here to check it out.
Also Trade In: Germany
EMBED
10Y: -% Above Low: +NaN% Below High: NaN%
Peers
PE Ratio P/S Ratio P/B Ratio Price-FCF Ratio Market Cap
Current and historical daily P/E ratio for National Research Corp () from 1997 to Jan 22 2022. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. National Research stock (NRC) PE ratio as of Jan 22 2022 is 27.59. More Details

National Research PE Ratio (TTM) Chart

EMBED

National Research PE Ratio (TTM) Historical Data

Total 1222
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
National Research PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2022-01-2227.6 2021-11-2229.6
2022-01-2127.6 2021-11-1930.2
2022-01-2026.8 2021-11-1831.3
2022-01-1926.7 2021-11-1732.1
2022-01-1826.6 2021-11-1632.5
2022-01-1727.1 2021-11-1532.9
2022-01-1427.1 2021-11-1233.8
2022-01-1327.4 2021-11-1134.4
2022-01-1227.4 2021-11-1034.3
2022-01-1128.3 2021-11-0934.6
2022-01-1029.0 2021-11-0834.4
2022-01-0728.9 2021-11-0534.8
2022-01-0629.3 2021-11-0434.3
2022-01-0529.5 2021-11-0334.7
2022-01-0429.6 2021-11-0233.5
2022-01-0330.0 2021-11-0132.6
2021-12-3129.5 2021-10-2930.7
2021-12-3029.7 2021-10-2830.7
2021-12-2929.9 2021-10-2730.3
2021-12-2830.1 2021-10-2631.3
2021-12-2730.1 2021-10-2530.9
2021-12-2429.4 2021-10-2230.7
2021-12-2329.4 2021-10-2130.9
2021-12-2228.7 2021-10-2031.1
2021-12-2128.4 2021-10-1930.8
2021-12-2028.9 2021-10-1830.3
2021-12-1729.8 2021-10-1530.4
2021-12-1630.0 2021-10-1430.9
2021-12-1530.0 2021-10-1330.8
2021-12-1429.6 2021-10-1231.3
2021-12-1330.2 2021-10-1130.9
2021-12-1030.1 2021-10-0830.3
2021-12-0929.6 2021-10-0730.1
2021-12-0829.5 2021-10-0629.5
2021-12-0730.6 2021-10-0530.5
2021-12-0630.5 2021-10-0429.9
2021-12-0329.8 2021-10-0130.2
2021-12-0229.9 2021-09-3029.9
2021-12-0129.7 2021-09-2930.6
2021-11-3028.4 2021-09-2831.0
2021-11-2928.8 2021-09-2731.9
2021-11-2629.2 2021-09-2432.3
2021-11-2530.6 2021-09-2332.7
2021-11-2430.6 2021-09-2232.8
2021-11-2330.1 2021-09-2133.2

National Research PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

National Research Corp logo

Business Description

Industry
Healthcare » Medical Diagnostics & Research » NAICS : 621399 SIC : 8099
Traded in other countries / regions
Address
1245 Q Street, Lincoln, NE, USA, 68508
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. The solutions are offered at an enterprise level through the Voice of the Customer platform, The Governance Institute, and legacy Experience solutions. It operates in the US and Canada, of which key revenue is derived from the US.